Drug intelligence / Profile preview

euphol

Development stage
Preclinical
Lead developer
Hospital de Amor
Modality
Small Molecules
Administration
Oral, Intrathecal
01

Overview

Euphol is a tetracyclic triterpene alcohol isolated from the sap of plants in the *Euphorbiaceae* family, most notably *Euphorbia tirucalli* (pencil tree). It has demonstrated a broad range of pharmacological activities in preclinical studies, including anti-inflammatory, analgesic, and antineoplastic properties. In the context of neuro-oncology, euphol has shown significant therapeutic potential against high-grade gliomas (HGG), including glioblastoma (GBM) and pediatric HGG. Its mechanism of action involves the induction of apoptosis, inhibition of cell proliferation and migration, and modulation of signaling pathways such as protein kinase C (PKC). Euphol has also been found to sensitize glioma cells to the standard chemotherapy agent temozolomide (TMZ), suggesting its potential as a synergistic combination therapy for aggressive brain tumors. Research is primarily being conducted by academic and clinical institutions in Brazil and Portugal.

Other names
(24R)-eupha-8,24-dien-3-oleupha-8,24-dien-3-ol
02

Targets

PRKCA (Protein kinase C alpha)PRKCD (Protein kinase C delta)

Beyond the preview

Go deeper on euphol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on euphol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call